The investment-grade notes are due 2026, 2029, 2034 and 2054

Davis Polk advised the joint book-running managers and representatives of the several underwriters, in connection with the SEC-registered offering by Cardinal Health, Inc. of $500 million aggregate principal amount of its 4.700% notes due 2029, $750 million aggregate principal amount of its 5.000% notes due 2029, $1 billion aggregate principal amount of its 5.350% notes due 2034 and $650 million aggregate principal amount of its 5.750% notes due 2054. The proceeds will fund a portion of the consideration payable in connection with Cardinal Health, Inc.’s acquisition of the majority of outstanding equity interests of The GI Alliance Holdings, LLC and its acquisition of Advanced Diabetes Supply Group.

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions.

The Davis Polk capital markets team included partner John B. Meade and associates Steven Glendon and Maddie White. Partner James I. McClammy provided litigation advice. Partner Mario J. Verdolini and associates Michael Mirabella and Georgianna Eck provided tax advice. All members of the Davis Polk team are based in the New York office.

 

Copy link to share post